K251730 is an FDA 510(k) clearance for the LIA Console (542-7). This device is classified as a System, Imaging, Optical Coherence Tomography (oct) (Class II - Special Controls, product code NQQ).
Submitted by Leadoptik, Inc. (San Jose, US). The FDA issued a Cleared decision on December 19, 2025, 196 days after receiving the submission on June 6, 2025.
This device falls under the General & Plastic Surgery FDA review panel. Regulated under 21 CFR 892.1560. This Device Uses Back-reflected Light To Create Two-dimensional Images Versus Back-reflected Sound Waves As Are Used In Ultrasound Imaging..